Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study Randomized, Double-blind Study to Evaluate the Safety and Efficacy of 3 Doses of Doxycycline as Compared to Placebo in the Treatment of Moderate to Severe Facial Acne Vulgaris

NCT00612573 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.

NCT NCT00612573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00612573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study Randomized, Double-blind Study to Evaluate the Safety and Efficacy of 3 Doses of Doxycycline as Compared to Placebo in the Treatment of Moderate to Severe Facial Acne Vulgaris
Lead sponsor
Warner Chilcott
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
December 31, 2008
Enrollment
257 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris